Literature DB >> 932424

Antibody-mediated basophil accumulations in cutaneous hypersensitivity reactions of guinea pigs.

P W Askenase, J D Haynes, B J Hayden.   

Abstract

Cutaneous basophil hypersensitivity (CBH) was studied in guinea pigs by using simplified histologic techniques. Animals immunized with oxazolone or picryl conjugates of keyhole limpet hemocyanin (KLH) emulsified with complete (CFA) or incomplete Freund's adjunvant (IFA) were found to have hapten-specific cutaneous basophil reactions when skin tested at 1 week with oxazolone or picryl chloride contant painting or intradermal injection of oxazolone or picryl-conjugated human serum albumin, respectively. Thus, hapten-specific cutaneous basophil reactions were present in guinea pigs immunized with CFA for classical delayed hypersensitivity, and in animals immunized with IFA for Jones-Mote reactions. Hapten-specific 24-hr cutaneous basophil reactions were passively transferred with immune serum from donors sensitized with conjugates of oxazolone or picryl-KLH in CFA or IFA, and with serum from oxazolone contact-sensitized animals as well. As little as 0.5 ml sera obtained from donors 1 week after immunization could systemically transfer cutaneous basophil reactions. It is likely that hapten-specific cutaneous basophil reactions are mediated by small quantities of serum antibodies. We conclude that antibody-mediated cutaneous basophil reactions may be distinctive hypersensitivity responses that can be distinguished from classical anaphylactic, Arthus, and delayed hypersensitivities. It is suggested that CBH reactions are heterogeneous and that antibody products of B lymphocytes, and factors probably derived from T lymphocytes, play a role in basophil accumulations at cutaneous hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932424

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Inflammatory response linked to oxazolone-indued cutaneous basophil hypersensitivity: effect of different immunomodulator and anti-inflammatory drugs.

Authors:  J Bure; F Degrand
Journal:  Agents Actions       Date:  1979-12

Review 2.  Human mast cells and basophils--structure, function, pharmacology, and biochemistry.

Authors:  R P Schleimer; D W MacGlashan; E S Schulman; S P Peters; G K Adams; N F Adkinson; L M Lichtenstein
Journal:  Clin Rev Allergy       Date:  1983-09

3.  Response of intestinal globule leucocytes in the mouse during a Trichinella spiralis infection and its independence of intestinal mast cells.

Authors:  E J Ruitenberg; A Elgersma
Journal:  Br J Exp Pathol       Date:  1979-06

4.  Dissociation of erythema and basophil accumulation in Jones-Mote type hypersensitivity in the guinea-pig.

Authors:  S Yoshida; K Nomoto; K Himeno
Journal:  Br J Exp Pathol       Date:  1979-12

5.  Acquired resistance in dogs to repeated infestation with Ixodes scapularis (Acari: Ixodidae) reduces tick viability and reproductive success.

Authors:  J A Gebbia; E M Bosler; R D Evans; E M Schneider
Journal:  Exp Appl Acarol       Date:  1995-10       Impact factor: 2.132

6.  Comparability of delayed hypersensitivity in various rodents. II. Jones-Mote type hypersensitivity in guinea-pigs immunized with sheep erythrocytes and its modification by cyclophosphamide or BCG pre-treatment.

Authors:  K Nomoto; S Yoshida; K Himeno
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

7.  The role of basophils and mast cells in cutaneous basophil hypersensitivity reaction.

Authors:  T Kishimoto; R Soda; K Takahashi; I Kimura
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

8.  Differentiation and activity of mast cells following immunization in cultures of lymph-node cells.

Authors:  H Ginsburg; I Nir; I Hammel; R Eren; B A Weissman; Y Naot
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

9.  Immunologic and nonimmunologic generation of superoxide from mast cells and basophils.

Authors:  W R Henderson; M Kaliner
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.